Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00070499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00070499
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-15
- Primary completion
- 2010-11-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.